Center for Clinical Studies, Texas Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2002
NCT01250561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Center for Clinical Studies | Center for Clinical Studies, Texas

Active Ingredients

Drugs in Phase 1 Trials (1)

ingenol mebutate (picato) (1 trial)

Drugs in Other Trials (3)

gabapentin (neurontin) (1 trial)

oatmeal (1 trial)

valaciclovir (Valtrex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Molluscum Contagiosum (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 4